4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001231427-26-000002
Director sold 2,910 shares at $569.00 ($1,655,790)
- Director acquired 2,910 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
PATUSKY CHRISTOPHER · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,910 | $101.80 | $296,238 | 4,400 | D |
| 2026-04-24 | Sale : show line 2 in the form 10b5-1 | −2,910 | $569.00 | $1,655,790 | 1,490 | D |
| Open-market sales · 2,910 sh · avg $569.00 · $1,655,790 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-24 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option | −2,910 | 0 | D |
Loading xslF345X06/primarydocument.xml…